ROTH Capital Partners' Joseph Pantginis Interviewed by The Life Sciences Report Apr 28, 2016 09:00AM
Roth Capital Starts Immune Pharmaceuticals (IMNP) at Buy Oct 8, 2015 08:15AM
Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors Jul 29, 2015 04:15PM